Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nonseminomatous germ cell tumor × BEP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nonseminomatous germ cell tumor 1

Interventions

Etoposide 2 Drug Therapy 2 tremelimumab 1 trametinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 etoposide phosphate 1 durvalumab 1 dabrafenib 1 cabozantinib 1 cabazitaxel 1 Paclitaxel 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Brentuximab Vedotin 1 BEP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05705687 2025-05-08

VAPOR

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Recruiting

Nonseminomatous germ cell tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡